DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Position Increased by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. lifted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 123.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,706 shares of the medical instruments supplier’s stock after buying an additional 7,583 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $488,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of XRAY. VisionPoint Advisory Group LLC raised its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the period. Point72 Asset Management L.P. acquired a new position in DENTSPLY SIRONA during the second quarter valued at $44,000. Parkside Financial Bank & Trust raised its position in DENTSPLY SIRONA by 163.7% during the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 568 shares during the period. Anchor Investment Management LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at $47,000. Finally, Exchange Traded Concepts LLC raised its position in DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 439 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $30.50 on Friday. The business has a 50 day moving average price of $32.79 and a 200 day moving average price of $32.84. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $43.24. The company has a market cap of $6.32 billion, a price-to-earnings ratio of -49.19, a PEG ratio of 1.23 and a beta of 0.98. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $972.61 million. During the same quarter in the prior year, the company earned $0.46 EPS. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. Research analysts predict that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.10%. DENTSPLY SIRONA’s dividend payout ratio is -103.23%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on XRAY shares. Needham & Company LLC reissued a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. SVB Leerink started coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an “outperform” rating and a $42.00 target price on the stock. Barrington Research restated an “outperform” rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday. Finally, StockNews.com upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.